IL101139A - Imidazoacridines and their use against large malignancies - Google Patents

Imidazoacridines and their use against large malignancies

Info

Publication number
IL101139A
IL101139A IL10113992A IL10113992A IL101139A IL 101139 A IL101139 A IL 101139A IL 10113992 A IL10113992 A IL 10113992A IL 10113992 A IL10113992 A IL 10113992A IL 101139 A IL101139 A IL 101139A
Authority
IL
Israel
Prior art keywords
alkyl
compound
compounds
formula
hydrogen
Prior art date
Application number
IL10113992A
Other languages
English (en)
Hebrew (he)
Other versions
IL101139A0 (en
Original Assignee
Britsh Technology Group Limite
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Britsh Technology Group Limite filed Critical Britsh Technology Group Limite
Publication of IL101139A0 publication Critical patent/IL101139A0/xx
Publication of IL101139A publication Critical patent/IL101139A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL10113992A 1991-03-05 1992-03-04 Imidazoacridines and their use against large malignancies IL101139A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919104548A GB9104548D0 (en) 1991-03-05 1991-03-05 Antineoplastic modified imidazoacridines

Publications (2)

Publication Number Publication Date
IL101139A0 IL101139A0 (en) 1992-11-15
IL101139A true IL101139A (en) 1995-01-24

Family

ID=10690967

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10113992A IL101139A (en) 1991-03-05 1992-03-04 Imidazoacridines and their use against large malignancies

Country Status (17)

Country Link
US (1) US5231100A (de)
EP (2) EP0502668A1 (de)
JP (1) JP3176062B2 (de)
AT (1) ATE153664T1 (de)
AU (1) AU654700B2 (de)
CA (1) CA2051356C (de)
DE (1) DE69220048T2 (de)
DK (1) DK0579614T3 (de)
ES (1) ES2103931T3 (de)
GB (2) GB9104548D0 (de)
GR (1) GR3024485T3 (de)
IE (1) IE66260B1 (de)
IL (1) IL101139A (de)
NO (1) NO300175B1 (de)
PL (1) PL167640B1 (de)
WO (1) WO1992015583A1 (de)
ZA (1) ZA921615B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2111902A1 (en) * 1992-12-21 1994-06-22 Jack Beuford Campbell Antitumor compositions and methods of treatment
US5508289A (en) * 1994-03-14 1996-04-16 The United States America As Represented By The Department Of Health And Human Services Bis-acridone chemotherapeutic derivatives
WO1997016191A1 (en) * 1995-11-02 1997-05-09 Warner-Lambert Company Inhibition of amyloidosis by 9-acridinones
AU725629B2 (en) 1996-04-12 2000-10-19 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Acridone-derived compounds useful as antineoplastic and antiretroviral agents
GB2317888A (en) 1996-10-07 1998-04-08 Marek Tadeusz Konieczny Acridone derivatives and preparation of 8-hydroxy-imidazoacridinone derivatives
IT1293525B1 (it) * 1997-08-01 1999-03-01 Uni Degli Studi Camerino Bis-acridincarbossiammidi aventi attivita' antitumorale
AU4005401A (en) 2000-03-07 2001-09-17 Us Health 1,8-naphthalimide imidazo(4,5,1-de)acridones with anti-tumor activity
CA2596144A1 (en) * 2005-01-28 2006-08-03 Xanthus Pharmaceuticals, Inc. Compounds for treating inflammatory and demyelinating diseases
WO2007092436A2 (en) * 2006-02-08 2007-08-16 Xanthus Pharmaceuticals, Inc. Compounds for treating inflammatory disorders, demyelinating disorders and cancers
WO2007143096A2 (en) * 2006-06-02 2007-12-13 Xanthus Pharmaceuticals, Inc. Compounds for treating cancers
WO2008016700A2 (en) * 2006-08-02 2008-02-07 Xanthus Pharmaceuticals, Inc. N-oxide compounds for therapeutics uses
WO2008016665A2 (en) * 2006-08-02 2008-02-07 Xanthus Pharmaceuticals, Inc. Imidazoacridine compounds for treating flt3 -mediated disorders
WO2008016660A2 (en) * 2006-08-02 2008-02-07 Xanthus Pharmaceuticals, Inc. Imidazoacridine compounds for treating leukemias
US20080118576A1 (en) * 2006-08-28 2008-05-22 Dan Theodorescu Prediction of an agent's or agents' activity across different cells and tissue types
US8470844B2 (en) * 2008-09-11 2013-06-25 Technion Research & Development Foundation Limited Imidazoacridinone derivative compounds and methods for their use
EP3070078B1 (de) * 2015-03-20 2017-10-04 Politechnika Gdanska Unsymmetrische bisacridine und ihre verwendung zur behandlung von tumoren
CA2986202C (en) 2015-04-27 2023-08-22 The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center Egr1 targeting molecules for the treatment of inflammatory and hyperproliferative conditions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1037377A (en) * 1964-09-02 1966-07-27 Mitsubishi Chem Ind Naphthoylene-arylimidazole disperse dyestuffs
US4626540A (en) * 1983-11-08 1986-12-02 Warner-Lambert Company Substituted 1-amino-4-nitro-acridinones and methods of treating bacterial infections and leukemia with them
JP2795460B2 (ja) * 1988-06-20 1998-09-10 協和醗酵工業株式会社 ピラゾロアクリドン誘導体

Also Published As

Publication number Publication date
CA2051356C (en) 2002-01-08
GB9204315D0 (en) 1992-04-08
EP0579614B1 (de) 1997-05-28
IE66260B1 (en) 1995-12-27
DE69220048T2 (de) 1997-10-02
JPH06508102A (ja) 1994-09-14
DK0579614T3 (da) 1997-12-15
ZA921615B (en) 1992-11-25
GB9104548D0 (en) 1991-04-17
PL167640B1 (pl) 1995-10-31
NO300175B1 (no) 1997-04-21
GR3024485T3 (en) 1997-11-28
US5231100A (en) 1993-07-27
WO1992015583A1 (en) 1992-09-17
AU1274392A (en) 1992-10-06
JP3176062B2 (ja) 2001-06-11
NO933147D0 (no) 1993-09-03
GB2253396B (en) 1994-08-10
AU654700B2 (en) 1994-11-17
IE920677A1 (en) 1992-09-09
ES2103931T3 (es) 1997-10-01
NO933147L (no) 1993-09-03
ATE153664T1 (de) 1997-06-15
CA2051356A1 (en) 1992-09-06
DE69220048D1 (de) 1997-07-03
EP0502668A1 (de) 1992-09-09
IL101139A0 (en) 1992-11-15
GB2253396A (en) 1992-09-09
EP0579614A1 (de) 1994-01-26

Similar Documents

Publication Publication Date Title
IL101139A (en) Imidazoacridines and their use against large malignancies
Cholody et al. Chromophore-modified antineoplastic imidazoacridinones. Synthesis and activity against murine leukemias
AU740578B2 (en) Tetrahydropyrido compounds
NZ248841A (en) Pyrido[4,3-b]carbazole derivatives (or ellipticines) and medicaments
AU643539B2 (en) 1,2-dihydro-3H-dibenzisoquinoline-1,3-dione anticancer agents
PL192814B1 (pl) Związki akronicynowe, sposób ich wytwarzania i zawierające je kompozycje farmaceutyczne
JPH0730076B2 (ja) 新規なアクリジン化合物
AU707092B2 (en) Phenanthridine derivatives, method for producing the above medicines containing phenanthridine derivatives
Janin et al. Synthesis of some benzo [h] quinoline derivatives
US5854273A (en) Bisimide compounds
CS196388B2 (en) Method of producing novel pyridobenzodiazepinones
AU713107B2 (en) New pyrido-thiopyranoindazoles with antitumor activity
MXPA02001493A (es) Derivados fenantrolin-7-onas y sus aplicaciones terapeuticas..
WO1998049172A1 (en) Regioisomeric benzothiopyranopyridines having antitumor activity
ZA200308628B (en) Tricyclic dihydroquinoline compounds, a process for their preparation and pharmaceutical compositions containing them.
IE920704A1 (en) Nitrogen oxides of aza- and diaza-anthracenedione¹derivatives as antitumor agents
Croisy‐Delcey et al. Synthesis of 4‐Amino‐substituted‐6‐hydroxy and 11‐hydroxynaphtho [2, 3‐g] quinoline‐5, 12‐diones, and the unexpected formation of disubstituted imidazo [4, 5, l‐i, j] naphtho [2, 3‐g] quinolin‐7‐ones
KR810001132B1 (ko) 피리미드 퀴녹살린 유도체의 제조법
KR810001451B1 (ko) 피리도 벤조디아제피논의 제조방법
US20030212061A1 (en) Aza-thioxanthenones with antitumor activity
WO1994005641A1 (en) 4-SUBSTITUTED 6,9,-BIS (SUBSTITUTED-AMINO) BENZO [g] ISOQUINOLINE-5,10,DIONES
WO1998023618A1 (en) 2,3,4,7-tetrahydropyridoindazole[1,4] benzodiazepine derivatives having antitumor activity

Legal Events

Date Code Title Description
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees